SaludModerna’s mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the companies said, sending shares of the vaccine maker up 60% in premarket trading. https://cnn.it/4qqzOQ0
pendiente de traducción
C
CNN★★★☆☆2026-08-19 12:30Original
Moderna’s mRNA vaccine combined with Merck’s immunotherapy Keytruda succeeded in a late-stage trial for skin cancer, the companies said, sending shares of the vaccine maker up 60% in premarket trading. https://cnn.it/4qqzOQ0